Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Lag Estimates
COLLCollegium Pharmaceutical(COLL) Zacks Investment Research·2024-05-10 06:40

Collegium Pharmaceutical (COLL) came out with quarterly earnings of 1.45pershare,missingtheZacksConsensusEstimateof1.45 per share, missing the Zacks Consensus Estimate of 1.49 per share. This compares to earnings of 1.32pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof−2.681.32 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -2.68%. A quarter ago, it was expected that this specialty pharmaceutical company would post earnings of 1.33 per share when it actually produced earnings of $1.58, delivering a surprise of 18.80%. Over ...